doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: epinephrine

1 - 5 of 10 <<previous | next>>

Drugs results:

Meridia

Meridia

Meridia, or Sibutramine, is used together with a reduced-calorie diet to help you lose weight and to help keep the lost weight from returning. Meridia is thought to work by increasing the activity of norepinephrine and serotonin in th more...

Wellbutrin SR pills

Wellbutrin SR

Wellbutrin SR is the brand name for the generic drug bupropion. Other brand name packagings for this drug are Zyban SR, Wellbutrin SR XL, and Wellbutrin SR SR. This medication is an antidepressant, used to treat anxiety, seasonal affective disorder and more...

Cymbalta tablets

Cymbalta

Cymbalta, sometimes known as Duloxetine, is used to treat mental depression, and pain caused by nerve damage associated with diabetes. Cymbalta belongs to a group of medicines known as Selective Serotonin and Norepinephrine Reuptake Inhibitors (SSNRIs). T more...

Duloxetine pills

Duloxetine

Duloxetine is an antidepressant medication. It affects chemicals in the brain that may become unbalanced and cause depression. It is used to treat major depressive disorder (MDD) and for the management of pain associated with diabetic peripheral neuropat more...

Strattera tablet

Strattera

Strattera, or Atomoxetine, belongs to the group of medicines called selective norepinephrine reuptake inhibitors, and treats attention-deficit hyperactivity disorder (ADHD). Strattera increases attention and decreases restlessness, and is used as part of more...

Diseases results:

Obesity
Attention Deficit Disorder
Mental Health and Depression
ADHD
Irregular heartbeat
Alcohol withdrawal
Allergic reaction
Anaphylaxis
Croup

Articles results:

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New Product Launches And Novel Projects Moving Into Late-stage Trials
Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.




1 - 5 of 10 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.